The aptamer successfully targeted VEGF signaling in cisplatin-resistant cells via a nanoparticle chimera delivery system, which effectively knocked down the NOTCH3 gene for tumor regression in ovarian cancer 138. This evidence concerns the gene VEGFA and neoplasm.